Harpoon Therapeutics Inc reports results for the quarter ended in June - Earnings Summary

Harpoon Therapeutics

06/08/2021 02:17

* Harpoon Therapeutics Inc  HARP.OQ  reported a quarterly
adjusted loss of 52 cents​​ per share for the quarter ended in
June. The mean expectation of ten analysts for the quarter was
for a loss of 43 cents per share.
* Revenue rose 111.4% to $5.84 million from a year ago; 
analysts expected $6.94 million. 
* Harpoon Therapeutics Inc's reported EPS for the quarter was a
loss of 52 cents​.
* The mean earnings estimate of analysts had risen by about 4.1%
in the last three months.​ 
* In the last 30 days there have been no earnings estimate
revisions by analysts covering the company. 
* Harpoon Therapeutics Inc shares had fallen by 29.1% this
quarter and lost 40.8% so far this year.
* The company reported a quarterly loss of $16.76 million.
* Wall Street's median 12-month price target for Harpoon
Therapeutics Inc is $31.00 
* The current average analyst rating on the shares is "buy" and
the breakdown of recommendations is 8 "strong buy" or "buy," 2
"hold" and no "sell" or "strong sell." 
This summary was machine generated August 6 at 01:17 a.m.  ​All
figures in US dollars unless otherwise stated